6/26/2019  6:28:20 PM Chg. -2.22 Volume Bid6:29:07 PM Ask- Market Capitalization Dividend Y. P/E Ratio
201.58USD -1.09% 15,422
Turnover: 3.11 mill.
201.56Bid Size: 100 -Ask Size: - 76.18 bill.USD 0.92% 21.45

Business description

Stryker is one of the world's leading medical technology companies and, together with its customers, is driven to make healthcare better. The company offers innovative products and services in Orthopaedics, Medical and Surgical, and Neurotechnology and Spine that help improve patient and hospital outcomes.
 

Management board & Supervisory board

CEO
Kevin A. Lobo
Management board
Glenn Boehnlein, Andy Pierce, Bijoy Sagar, Bronwen R. Taylor, David G. Furgason, David K. Floyd (bis 30.06.2019), Dean H. Bergy, Irene B. Corbe, Jeanne M. Blondia, Katherine A. Owen, Lonny J. Carpenter, M. Kathryn Fink, Rob Fletcher, Spencer Stiles, Timothy J. Scannel, Viju Menon, William E. Berry Jr., William J. Cymbaluk, Yin C. Becker
Supervisory board
Kevin A. Lobo, Allan C. Golston, Andrew K. Silvernail, Dr. Roch Doliveux, Dr. Srikant M. Datar, Louise L. Francesconi, Mary K. Brainerd, Rajeev Suri, Ronda E. Stryker, Sherilyn S. McCoy
 

Company data

Name: Stryker Corporation
Address: 2825 Airview Boulevard,Kalamazoo, Michigan 49002, USA
Phone: +1-269-385-2600
Fax: +1-616-385-1062
E-mail: -
Internet: www.stryker.com
Industry: Healthcare
Sector: Pharmaceutical Industry
Sub sector: Pharmaceuticals
End of financial year: 12/31
Free Float: 59.90%
IPO date: -

Investor relations

Name: Katherine A. Owen
IR phone: -
IR-Fax: -
IR e-mail: katherine.owen@stryker.com

Main Shareholders

Freefloat
 
59.90%
T. Rowe Price Associates, Inc.
 
8.70%
The Vanguard Group, Inc.
 
7.00%
BlackRock, Inc.
 
6.60%
Ronda E. Stryker
 
6.60%
Greenleaf Trust
 
5.90%
John W. Brown
 
5.30%